Predictors of short-term impulsive and compulsive behaviour after subthalamic stimulation in Parkinson disease
Open Access
- 11 September 2021
- journal article
- research article
- Published by BMJ in Journal of Neurology, Neurosurgery & Psychiatry
- Vol. 92 (12), 1313-1318
- https://doi.org/10.1136/jnnp-2021-326131
Abstract
Background The effects of subthalamic stimulation (subthalamic nucleus-deep brain stimulation, STN-DBS) on impulsive and compulsive behaviours (ICB) in Parkinson’s disease (PD) are understudied. Objective To investigate clinical predictors of STN-DBS effects on ICB. Methods In this prospective, open-label, multicentre study in patients with PD undergoing bilateral STN-DBS, we assessed patients preoperatively and at 6-month follow-up postoperatively. Clinical scales included the Questionnaire for Impulsive-Compulsive Disorders in PD-Rating Scale (QUIP-RS), PD Questionnaire-8, Non-Motor Symptom Scale (NMSS), Unified PD Rating Scale in addition to levodopa-equivalent daily dose total (LEDD-total) and dopamine agonists (LEDD-DA). Changes at follow-up were analysed with Wilcoxon signed-rank test and corrected for multiple comparisons (Bonferroni method). We explored predictors of QUIP-RS changes using correlations and linear regressions. Finally, we dichotomised patients into ‘QUIP-RS improvement or worsening’ and analysed between-group differences. Results We included 55 patients aged 61.7 years±8.4 with 9.8 years±4.6 PD duration. QUIP-RS cut-offs and psychiatric assessments identified patients with preoperative ICB. In patients with ICB, QUIP-RS improved significantly. However, we observed considerable interindividual variability of clinically relevant QUIP-RS outcomes as 27.3% experienced worsening and 29.1% an improvement. In post hoc analyses, higher baseline QUIP-RS and lower baseline LEDD-DA were associated with greater QUIP-RS improvements. Additionally, the ‘QUIP-RS worsening’ group had more severe baseline impairment in the NMSS attention/memory domain. Conclusions Our results show favourable ICB outcomes in patients with higher preoperative ICB severity and lower preoperative DA doses, and worse outcomes in patients with more severe baseline attention/memory deficits. These findings emphasise the need for comprehensive non-motor and motor symptoms assessments in patients undergoing STN-DBS. Trial registration number DRKS00006735.Funding Information
- Parkinson's UK (funding ID Parkinson's UK K-1406)
This publication has 43 references indexed in Scilit:
- Effects of STN and GPi Deep Brain Stimulation on Impulse Control Disorders and Dopamine Dysregulation SyndromePLOS ONE, 2012
- Health-related quality of life as an outcome variable in Parkinson’s diseaseTherapeutic Advances in Neurological Disorders, 2011
- Questionnaire for impulsive‐compulsive disorders in Parkinson's Disease–Rating ScaleMovement Disorders, 2011
- Validation of the questionnaire for impulsive‐compulsive disorders in Parkinson's diseaseMovement Disorders, 2009
- Dopamine and impulse control disorders in Parkinson's diseaseAnnals of Neurology, 2009
- The metric properties of a novel non‐motor symptoms scale for Parkinson's disease: Results from an international pilot studyMovement Disorders, 2007
- A Randomized Trial of Deep-Brain Stimulation for Parkinson's DiseaseThe New England Journal of Medicine, 2006
- The Unified Parkinson's Disease Rating Scale (UPDRS): Status and recommendationsMovement Disorders, 2003
- The PDQ-8: Development and validation of a short-form parkinson's disease questionnairePsychology & Health, 1997
- ParkinsonismNeurology, 1967